Hybrid (minimum of three days per week in the office, with respect for individual flexibility)
Sophisticated scientific degree required
7+ years pharmaceutical industry experience
Respiratory disease medical expertise
AstraZeneca is seeking a US Medical Head for COPD Biologics to lead the medical strategy and execution of a novel product targeting chronic respiratory diseases. The role requires a sophisticated scientific background, extensive experience in the pharmaceutical industry, and strong leadership capabilities to drive team performance and product launches
Job Summary
This role leads the medical strategy and execution for a novel Interleukin-33 targeting monoclonal antibody within the COPD biologics space.
The successful candidate will co-lead the Core Value Team with Commercial and Market Access leaders to deliver a cohesive launch plan.
AstraZeneca fosters an inclusive environment where medical leaders sit at the intersection of science and real-world practice to transform patient outcomes.
Matching Summary
Match Score: 85
AstraZeneca is seeking a US Medical Head for COPD Biologics to lead the medical strategy and execution of a novel product targeting chronic respiratory diseases. The role requires a sophisticated scientific background, extensive experience in the pharmaceutical industry, and strong leadership capabilities to drive team performance and product launches.
Skills & Requirements
Must-have
Sophisticated scientific degree required
7+ years pharmaceutical industry experience
Respiratory disease medical expertise
Team leadership in matrix environment
US product launch experience
Regulatory strategy knowledge
Nice-to-have
Leadership in US Medical Affairs respiratory biologics
Real-world evidence program development
Cross-functional investment decision influence
External authority relationship building
Field medical team collaboration
Key Requirements
MBBS, PharmD, PhD, or MD degree
Minimum 7 years pharmaceutical industry experience
Experience launching new products in US market
Knowledge of US Regulatory Strategy and label requirements